Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GENTEX CORPGNTX · Entity 3954 | Chief Financial Officer | February 17, 2026 | February 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GENTEX CORP
Report date February 17, 2026 · Filed February 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,310 |
Ending reported balance
After 2026-02-19 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-02-17 · Grant · Acquired 38,181 · Balance 92,485 F1: 38,181 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. Row 2 · 2026-02-17 · Tax withholding · Disposed 16,864 · Balance 75,621 Row 3 · 2026-02-17 · Tax withholding · Disposed 4,306 · Balance 71,315 Row 4 · 2026-02-17 · Sale · Disposed 6,317 · Balance 64,998 Row 5 · 2026-02-17 · Sale · Disposed 5,568 · Balance 59,430 Row 6 · 2026-02-19 · Grant · Acquired 13,880 · Balance 73,310 F2: These shares vest 100% three years from grant award date. |
Filing footnotes · ownership attribution and instrument terms
F1: 38,181 shares are performance-based shares where the total number of shares granted were based on long term performance incentives.
F2: These shares vest 100% three years from grant award date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2026 Filed Feb 19, 2026 21:38 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 13,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001577359-26-000001 · primarydocument.xml · nonDerivative · entry 6 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,310 F2 · kind: These shares vest 100% three years from grant award date. Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:38 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 5,568 | $24.98 | $139,070.27 |
DisclosureSEC source: 0001577359-26-000001 · primarydocument.xml · nonDerivative · entry 5 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,430 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:38 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 6,317 | $24.98 | $157,777.81 |
DisclosureSEC source: 0001577359-26-000001 · primarydocument.xml · nonDerivative · entry 4 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,998 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:38 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 4,306 | $24.89 | $107,176.34 |
DisclosureSEC source: 0001577359-26-000001 · primarydocument.xml · nonDerivative · entry 3 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,315 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:38 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 16,864 | $24.89 | $419,744.96 |
DisclosureSEC source: 0001577359-26-000001 · primarydocument.xml · nonDerivative · entry 2 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,621 Read SEC document |
| February 17, 2026 Filed Feb 19, 2026 21:38 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 38,181 | $0.00 | $0.00 |
DisclosureSEC source: 0001577359-26-000001 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,485 F1 · kind: 38,181 shares are performance-based shares where the total number of shares granted were based on long term performance incentives. Read SEC document |
| August 26, 2025 Filed Aug 27, 2025 20:37 UTC | GENTEX CORP GNTX · Entity 3954 | GiftCommon Stock | 865 | $28.28 | $24,462.20 |
DisclosureSEC source: 0001562180-25-006021 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,304 F1 · balance_after: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 16:09 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 11,836 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-001461 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,101 F1 · shares: These shares vest 100% three years from grant award date. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:10 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 8,386 | $24.62 | $206,488.48 |
DisclosureSEC source: 0001562180-25-001298 · primarydocument.xml · nonDerivative · entry 3 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,265 F2 · price: This transaction was executed in multiple trades at prices ranging from $24.36 to $24.78. The price reported above reflects the weighted average price. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:10 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 7,456 | $24.62 | $183,589.09 |
DisclosureSEC source: 0001562180-25-001298 · primarydocument.xml · nonDerivative · entry 2 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,651 F2 · price: This transaction was executed in multiple trades at prices ranging from $24.36 to $24.78. The price reported above reflects the weighted average price. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 21:10 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 15,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-001298 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,107 F1 · kind: 15,617 shares are performance based shares where the total number of shares granted were based on long term performance incentives. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 15:57 UTC | GENTEX CORP GNTX · Entity 3954 | GiftCommon Stock | 1,831 | $36.53 | $66,886.43 |
DisclosureSEC source: 0001562180-24-002003 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,490 Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:07 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 13,500 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001562180-24-001471 · primarydocument.xml · derivative · entry 6 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2028-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:07 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 13,500 | $33.04 | $446,087.25 |
DisclosureSEC source: 0001562180-24-001471 · primarydocument.xml · nonDerivative · entry 5 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,321 F3 · price: This transaction was executed in multiple trades at prices ranging from $35.01 to $35.14. The price reported above reflects the weighted average price. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:07 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 13,500 | $22.94 | $309,690.00 |
DisclosureSEC source: 0001562180-24-001471 · primarydocument.xml · nonDerivative · entry 4 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:07 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 2,944 | $35.01 | $103,072.68 |
DisclosureSEC source: 0001562180-24-001471 · primarydocument.xml · nonDerivative · entry 3 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,321 F2 · price: This transaction was executed in multiple trades at prices ranging from $34.72 to $35.14. The price reported above reflects the weighted average price. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:07 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 4,191 | $35.01 | $146,731.52 |
DisclosureSEC source: 0001562180-24-001471 · primarydocument.xml · nonDerivative · entry 2 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,265 F2 · price: This transaction was executed in multiple trades at prices ranging from $34.72 to $35.14. The price reported above reflects the weighted average price. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 20:07 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 8,726 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001471 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,456 F1 · kind: 8,726 shares are performance based shares where the total number of shares granted were based on long term performance incentives. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 19:39 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 9,146 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001369 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,730 F1 · shares: These shares vest 100% three years from grant award date. Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 15:48 UTC | GENTEX CORP GNTX · Entity 3954 | GiftCommon Stock | 200 | $29.73 | $5,946.00 |
DisclosureSEC source: 0001562180-23-007634 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,584 Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 12:58 UTC | GENTEX CORP GNTX · Entity 3954 | GiftCommon Stock | 300 | $32.58 | $9,772.50 |
DisclosureSEC source: 0001562180-23-006425 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,784 Read SEC document |
| February 21, 2023 Filed Feb 21, 2023 20:20 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 2,414 | $28.65 | $69,161.10 |
DisclosureSEC source: 0001562180-23-001570 · primarydocument.xml · nonDerivative · entry 4 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,084 Read SEC document |
| February 21, 2023 Filed Feb 21, 2023 20:20 UTC | GENTEX CORP GNTX · Entity 3954 | Tax withholdingCommon Stock | 3,102 | $28.65 | $88,872.30 |
DisclosureSEC source: 0001562180-23-001570 · primarydocument.xml · nonDerivative · entry 3 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,498 Read SEC document |
| February 21, 2023 Filed Feb 21, 2023 20:20 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 7,129 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001570 · primarydocument.xml · nonDerivative · entry 2 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,600 F2 · kind: 7,129 shares are performance based shares where the total number of shares granted were based on long term performance incentives. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 20:20 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 9,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001570 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,471 F1 · shares: These shares vest 100% three years from grant award date. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 15:12 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 6,776 | $0.00 Strike: $14.70 | $0.00 |
DisclosureSEC source: 0001562180-23-000792 · primarydocument.xml · derivative · entry 3 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,776 shares Expires 2023-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These shares become exercisable as to 20% one year after date of grant and an additional 20% at each ensuing anniversary date. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 15:12 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 6,776 | $29.42 | $199,372.28 |
DisclosureSEC source: 0001562180-23-000792 · primarydocument.xml · nonDerivative · entry 2 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,597 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $29.32 to $29.56. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 865 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 15:12 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 6,776 | $14.70 | $99,607.20 |
DisclosureSEC source: 0001562180-23-000792 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:59 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 10,052 | $30.36 | $305,202.84 |
DisclosureSEC source: 0001562180-22-001716 · primarydocument.xml · nonDerivative · entry 3 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,732 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:59 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 10,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001716 · primarydocument.xml · nonDerivative · entry 2 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,784 F3 · kind: 10,052 shares are performance based shares where the total number of shares granted were based on long term performance incentives as disclosed on Form 10K filed on February 23, 2022. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 18:59 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 5,666 | $30.36 | $172,033.36 |
DisclosureSEC source: 0001562180-22-001716 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,732 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.02 to $30.86. The price reported above reflects the weighted average price. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 13:17 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 8,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-001657 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,398 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 15:12 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 3,630 | $31.32 | $113,695.96 |
DisclosureSEC source: 0001562180-22-001532 · primarydocument.xml · nonDerivative · entry 2 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,012 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $31.16 to $31.48. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 329 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 15:12 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 8,000 | $31.50 | $251,985.60 |
DisclosureSEC source: 0001562180-22-001532 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,642 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $31.06 to $31.84. The price reported above reflects the weighted average price. F3 · balance_after: Column 5 reflects the acquisition of 329 shares under the Gentex Corp. Employee Stock Purchase Plan. Read SEC document |
| February 22, 2021 Filed Feb 23, 2021 19:22 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 3,150 | $35.57 | $112,042.98 |
DisclosureSEC source: 0001562180-21-001436 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,313 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.34 to $35.85. The price reported above reflects the weighted average price. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 17:40 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 6,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-21-001359 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,463 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 22:11 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 2,922 | $35.73 | $104,412.99 |
DisclosureSEC source: 0001562180-21-001216 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,118 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.53 to $35.88. The price reported above reflects the weighted average price. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 18:05 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 5,864 | $0.00 Strike: $13.39 | $0.00 |
DisclosureSEC source: 0001562180-20-006814 · primarydocument.xml · derivative · entry 5 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,864 shares Expires 2021-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options are fully vested. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 18:05 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionEmployee Stock Option (Right to buy) · Derivative | 4,836 | $0.00 Strike: $15.50 | $0.00 |
DisclosureSEC source: 0001562180-20-006814 · primarydocument.xml · derivative · entry 4 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,836 shares Expires 2022-09-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Options are fully vested. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 18:05 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 10,700 | $33.18 | $355,040.98 |
DisclosureSEC source: 0001562180-20-006814 · primarydocument.xml · nonDerivative · entry 3 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,040 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.10 to $33.30. The price reported above reflects the weighted average price. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 18:05 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 5,864 | $13.39 | $78,489.64 |
DisclosureSEC source: 0001562180-20-006814 · primarydocument.xml · nonDerivative · entry 2 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 18:05 UTC | GENTEX CORP GNTX · Entity 3954 | Exercise / conversionCommon Stock | 4,836 | $15.50 | $74,958.00 |
DisclosureSEC source: 0001562180-20-006814 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 17:08 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 3,000 | $25.81 | $77,439.60 |
DisclosureSEC source: 0001562180-20-006198 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,040 F1 · price: This transaction was executed in multiple trades at prices ranging from $25.66 to $26.01. The price reported above reflects the weighted average price. Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 16:20 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 539 | $18.53 | $9,987.67 |
DisclosureSEC source: 0001562180-20-002766 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,040 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 20:09 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 5,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-001545 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,501 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation Restricted Stock Plan, which is a Rule 16B-3 Plan. Read SEC document |
| October 01, 2019 Filed Oct 2, 2019 21:41 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 12,000 | $27.49 | $329,884.80 |
DisclosureSEC source: 0001562180-19-005076 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,966 F1 · price: This transaction was executed in multiple trades at prices ranging from $27.29 to $27.82. The price reported above reflects the weighted average price. Read SEC document |
| March 29, 2019 Filed Apr 1, 2019 14:12 UTC | GENTEX CORP GNTX · Entity 3954 | PurchaseCommon Stock | 568 | $17.58 | $9,985.44 |
DisclosureSEC source: 0001562180-19-002059 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,966 F1 · kind: Shares purchased through the Gentex Corporation Employee Stock Purchase Plan, a Section 423(b) plan Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 22:16 UTC | GENTEX CORP GNTX · Entity 3954 | GrantCommon Stock | 5,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-19-001279 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,398 F1 · shares: These shares vest 100% three years from grant award date. F2 · price: Shares granted under the Gentex Corporation 2019 Omnibus Incentive Plan, which is a Rule 16B-3 Plan; pending shareholder approval. Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 15:10 UTC | GENTEX CORP GNTX · Entity 3954 | SaleCommon Stock | 6,000 | $21.50 | $128,998.80 |
DisclosureSEC source: 0001562180-18-004056 · primarydocument.xml · nonDerivative · entry 1 Nash Kevin C · CIK 0001577359 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,732 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.30 to $21.66. The price reported above reflects the weighted average price. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 18:52 UTC | GENTEX CORP GNTX · Entity 3954 | GrantEmployee Stock Option (Right to buy) · Derivative | 27,000 | $22.94 Strike: $22.94 | $619,380.00 |
DisclosureSEC source: 0001562180-18-001069 · primarydocument.xml · derivative · entry 2 Nash Kevin C · CIK 0001577359 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires 2028-02-15 F3 · price: Options granted under the Gentex Corporation Employee Stock Option Plan, which is a Rule 16B-3 Plan. F4 · derivative.exercise_date: These shares become exercisable as to 25% one year after date of grant and an additional 25% at each ensuing anniversary date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.